Evaluation of postcontrast images of intracranial tumors at 7T and 3T MRI: An intra-individual comparison study

CNS Neurosci Ther. 2023 Feb;29(2):559-565. doi: 10.1111/cns.14036. Epub 2022 Dec 5.

Abstract

Aim: This study aimed to evaluate the diagnostic value of ultrahigh-field magnetic resonance imaging (MRI) for brain tumors in clinical practice.

Methods: Thirty patients with brain tumors underwent 7- and 3-T MRI. The performance and diagnostic confidence of 7- and 3-T MRI in the visualization of tumor details such as internal structure and feeding artery were evaluated by radiologists. Contrast-enhanced region performance and tumor detail diagnostic confidence score (DCS) were calculated and compared between 7 and 3T using Wilcoxon rank sum test.

Results: In 19 with obvious enhancement and 11 cases without obvious enhancement, 7- and 3-T MRI showed similar performance. The tumors' internal structure and feeding artery were more clearly depicted by 7-T MRI (62.2% and 54.4%, respectively) than by 3-T MRI (2.2% and 6.7%, respectively). Furthermore, the mean DCSs of both internal structure and feeding artery were higher at 7T than at 3T (internal structure: 16.29 ± 9.67 vs. -5.79 ± 4.12, p = 0.028; feeding artery: 21.96 ± 6.93 vs. 4.46 ± 7.07, p = 0.028). The DCS was more significantly improved in the senior radiologist group.

Conclusion: Better visualization of brain tumor details and higher tumor detail diagnostic confidence can be obtained with 7-T MRI.

Keywords: 7-T MRI; brain tumors; contrast-enhanced MRI; ultrahigh field.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Neoplasms* / diagnostic imaging
  • Humans
  • Magnetic Resonance Imaging* / methods